AIM ImmunoTech says Glass Lewis recommends shareholders vote for nominees

AIM ImmunoTech (AIM) announced that independent proxy advisory firm Glass, Lewis & Co., LLC has recommended that shareholders vote “FOR” company nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. Mitchell at the upcoming 2024 Annual Meeting of Stockholders, presently scheduled for December 17, 2024. In reaching its recommendation against giving the activist investors’ nominees control of the AIM Board of Directors, Glass Lewis noted the following: “…the (Activist Group’s) presented plan lacks substantive detail. For instance, it does not provide for a particular clinical strategy and relies on a full review of Ampligen’s indications to define such strategy, lacks a clear view on the Company’s management going forward, and does not indicate the less dilutive and less expensive financing options that may be available to the Company.” “… we do not believe the Dissident Group presented a fully qualified board slate of candidates to justify shareholder support of all four nominees.”